Anti‐Chi3L1 antibody‐treated tumor tissues promoted ARG1 and CD206 expression inhibition compared with vehicle‐treated tumor tissues but did not change iNOS and CD86 expression (Fig. 4C,D). This evidence concerns the gene CHI3L1 and neoplasm.